Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™

Clinical trial NCT00534833 · COMPLETED

Trial details

NCT number: NCT00534833
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Hepatitis B Haemophilus Influenzae Type b

Start date: 2007-09-01
Primary completion: 2008-09-01
Enrollment: 362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.